Loading…

Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals

Secretion of hydrolytic enzymes such as hemolysin is considered an important virulence attribute of the opportunistic pathogenic fungus Candida . It is known that Candida spp. isolated from HIV-infected patients produce copious hemolysins. As common antifungal agents may perturb the production of ex...

Full description

Saved in:
Bibliographic Details
Published in:Mycopathologia (1975) 2014-10, Vol.178 (3-4), p.207-215
Main Authors: Anil, Sukumaran, Hashem, Mohamed, Vellappally, Sajith, Patil, Shankargouda, Bandara, H. M. H. N., Samaranayake, L. P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13
cites cdi_FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13
container_end_page 215
container_issue 3-4
container_start_page 207
container_title Mycopathologia (1975)
container_volume 178
creator Anil, Sukumaran
Hashem, Mohamed
Vellappally, Sajith
Patil, Shankargouda
Bandara, H. M. H. N.
Samaranayake, L. P.
description Secretion of hydrolytic enzymes such as hemolysin is considered an important virulence attribute of the opportunistic pathogenic fungus Candida . It is known that Candida spp. isolated from HIV-infected patients produce copious hemolysins. As common antifungal agents may perturb the production of extracellular enzymes, we evaluated the effect of three antifungals nystatin, amphotericin B and fluconazole on the hemolytic activity of Candida albicans and Candida tropicalis isolates from HIV-infected individuals. The impact of antimycotics on hemolytic activity was assessed by a previously described in vitro plate assay, after exposing ten isolates each of C. albicans and C. tropicalis recovered from HIV-infected individuals to sub-minimum inhibitory concentrations (sub-MIC) of nystatin, amphotericin B and fluconazole. All Candida isolates showed a significant reduction in hemolytic activity. The reduction was highest for amphotericin B-exposed C. albicans and C. tropicalis followed by nystatin and fluconazole. The effect of antimycotics was more pronounced on the hemolytic activity of C. tropicalis compared to that of C. albicans . Commonly used antifungal agents significantly suppress hemolysin activity of Candida species. This implies that the antifungals, in addition to their lethality, may modulate key virulence attributes of the yeast. The clinical relevance of this phenomenon in HIV disease and other similar pathologies remains to be determined.
doi_str_mv 10.1007/s11046-014-9802-0
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1566828742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A385802486</galeid><sourcerecordid>A385802486</sourcerecordid><originalsourceid>FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13</originalsourceid><addsrcrecordid>eNp1ks9u1DAQxiMEokvhAbggS1zgkGI7iZMcVytgI1WqxALiZjn-s7hK7GA7Ffs0fdVOtKWwCOTDyOPfN_aMvyx7SfAFwbh-FwnBJcsxKfO2wTTHj7IVqeoix01BH2crXGCSlw37dpY9i_EaY1CR-ml2RitS0pqyVXa7m_vcuu-2t8mHA9p4J7VLQSTrXUTeoLVL1sxuL4aIdvM0BR0j2urRD4doHVrLZG9sOizoVRAD2ginrBJIDL2VAmrA_iGZgp8gO9iIuugHkXREJvgRbbuveeeMlkkr1AF8Y9UMVz7PnhgI-sV9PM--fHj_ebPNL68-dpv1ZS6rmqVclH2j2qKsGK4NbllREtwqjHXFmr5XRkktelpRXPWKNAL6byBDjWx73QpDivPszbHuFPyPWcfERxulHgbhtJ8jJxVjDW3qkgL6-i_02s_BwesWCtcFKyn7TcHgNLfOeBiqXIryddFU8F3wMUBd_IOCpfRopXfaWMifCN6eCIBJ-mfaizlG3u0-nbLkyMrgYwza8CnYUYQDJ5gvBuJHA3EwEF8MxDFoXt03N_ejVg-KX44BgB6BCEdur8Mf3f-36h1ZxdCj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1560736426</pqid></control><display><type>article</type><title>Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals</title><source>Springer Nature</source><creator>Anil, Sukumaran ; Hashem, Mohamed ; Vellappally, Sajith ; Patil, Shankargouda ; Bandara, H. M. H. N. ; Samaranayake, L. P.</creator><creatorcontrib>Anil, Sukumaran ; Hashem, Mohamed ; Vellappally, Sajith ; Patil, Shankargouda ; Bandara, H. M. H. N. ; Samaranayake, L. P.</creatorcontrib><description>Secretion of hydrolytic enzymes such as hemolysin is considered an important virulence attribute of the opportunistic pathogenic fungus Candida . It is known that Candida spp. isolated from HIV-infected patients produce copious hemolysins. As common antifungal agents may perturb the production of extracellular enzymes, we evaluated the effect of three antifungals nystatin, amphotericin B and fluconazole on the hemolytic activity of Candida albicans and Candida tropicalis isolates from HIV-infected individuals. The impact of antimycotics on hemolytic activity was assessed by a previously described in vitro plate assay, after exposing ten isolates each of C. albicans and C. tropicalis recovered from HIV-infected individuals to sub-minimum inhibitory concentrations (sub-MIC) of nystatin, amphotericin B and fluconazole. All Candida isolates showed a significant reduction in hemolytic activity. The reduction was highest for amphotericin B-exposed C. albicans and C. tropicalis followed by nystatin and fluconazole. The effect of antimycotics was more pronounced on the hemolytic activity of C. tropicalis compared to that of C. albicans . Commonly used antifungal agents significantly suppress hemolysin activity of Candida species. This implies that the antifungals, in addition to their lethality, may modulate key virulence attributes of the yeast. The clinical relevance of this phenomenon in HIV disease and other similar pathologies remains to be determined.</description><identifier>ISSN: 0301-486X</identifier><identifier>EISSN: 1573-0832</identifier><identifier>DOI: 10.1007/s11046-014-9802-0</identifier><identifier>PMID: 25142726</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Amphotericin B ; Amphotericin B - pharmacology ; Antifungal agents ; Antifungal Agents - pharmacology ; Antiparasitic agents ; Biocides ; Biomedical and Life Sciences ; Candida albicans ; Candida albicans - drug effects ; Candida albicans - isolation &amp; purification ; Candida albicans - metabolism ; Candida tropicalis ; Candida tropicalis - drug effects ; Candida tropicalis - isolation &amp; purification ; Candida tropicalis - metabolism ; Candidiasis, Oral - microbiology ; Dentistry ; Enzymes ; Eukaryotic Microbiology ; Fluconazole ; Fluconazole - pharmacology ; Fungi ; Health aspects ; Hemolysin Proteins - antagonists &amp; inhibitors ; Hemolysin Proteins - secretion ; HIV ; HIV (Viruses) ; HIV infection ; HIV Infections - complications ; HIV patients ; Human immunodeficiency virus ; Humans ; Infections ; Life Sciences ; Medical Microbiology ; Microbial Ecology ; Microbiological Techniques ; Microbiology ; Nystatin - pharmacology ; Plant Sciences ; Virulence ; Virulence (Microbiology) ; Virulence Factors - antagonists &amp; inhibitors ; Virulence Factors - metabolism</subject><ispartof>Mycopathologia (1975), 2014-10, Vol.178 (3-4), p.207-215</ispartof><rights>Springer Science+Business Media Dordrecht 2014</rights><rights>COPYRIGHT 2014 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13</citedby><cites>FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25142726$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anil, Sukumaran</creatorcontrib><creatorcontrib>Hashem, Mohamed</creatorcontrib><creatorcontrib>Vellappally, Sajith</creatorcontrib><creatorcontrib>Patil, Shankargouda</creatorcontrib><creatorcontrib>Bandara, H. M. H. N.</creatorcontrib><creatorcontrib>Samaranayake, L. P.</creatorcontrib><title>Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals</title><title>Mycopathologia (1975)</title><addtitle>Mycopathologia</addtitle><addtitle>Mycopathologia</addtitle><description>Secretion of hydrolytic enzymes such as hemolysin is considered an important virulence attribute of the opportunistic pathogenic fungus Candida . It is known that Candida spp. isolated from HIV-infected patients produce copious hemolysins. As common antifungal agents may perturb the production of extracellular enzymes, we evaluated the effect of three antifungals nystatin, amphotericin B and fluconazole on the hemolytic activity of Candida albicans and Candida tropicalis isolates from HIV-infected individuals. The impact of antimycotics on hemolytic activity was assessed by a previously described in vitro plate assay, after exposing ten isolates each of C. albicans and C. tropicalis recovered from HIV-infected individuals to sub-minimum inhibitory concentrations (sub-MIC) of nystatin, amphotericin B and fluconazole. All Candida isolates showed a significant reduction in hemolytic activity. The reduction was highest for amphotericin B-exposed C. albicans and C. tropicalis followed by nystatin and fluconazole. The effect of antimycotics was more pronounced on the hemolytic activity of C. tropicalis compared to that of C. albicans . Commonly used antifungal agents significantly suppress hemolysin activity of Candida species. This implies that the antifungals, in addition to their lethality, may modulate key virulence attributes of the yeast. The clinical relevance of this phenomenon in HIV disease and other similar pathologies remains to be determined.</description><subject>Amphotericin B</subject><subject>Amphotericin B - pharmacology</subject><subject>Antifungal agents</subject><subject>Antifungal Agents - pharmacology</subject><subject>Antiparasitic agents</subject><subject>Biocides</subject><subject>Biomedical and Life Sciences</subject><subject>Candida albicans</subject><subject>Candida albicans - drug effects</subject><subject>Candida albicans - isolation &amp; purification</subject><subject>Candida albicans - metabolism</subject><subject>Candida tropicalis</subject><subject>Candida tropicalis - drug effects</subject><subject>Candida tropicalis - isolation &amp; purification</subject><subject>Candida tropicalis - metabolism</subject><subject>Candidiasis, Oral - microbiology</subject><subject>Dentistry</subject><subject>Enzymes</subject><subject>Eukaryotic Microbiology</subject><subject>Fluconazole</subject><subject>Fluconazole - pharmacology</subject><subject>Fungi</subject><subject>Health aspects</subject><subject>Hemolysin Proteins - antagonists &amp; inhibitors</subject><subject>Hemolysin Proteins - secretion</subject><subject>HIV</subject><subject>HIV (Viruses)</subject><subject>HIV infection</subject><subject>HIV Infections - complications</subject><subject>HIV patients</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infections</subject><subject>Life Sciences</subject><subject>Medical Microbiology</subject><subject>Microbial Ecology</subject><subject>Microbiological Techniques</subject><subject>Microbiology</subject><subject>Nystatin - pharmacology</subject><subject>Plant Sciences</subject><subject>Virulence</subject><subject>Virulence (Microbiology)</subject><subject>Virulence Factors - antagonists &amp; inhibitors</subject><subject>Virulence Factors - metabolism</subject><issn>0301-486X</issn><issn>1573-0832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp1ks9u1DAQxiMEokvhAbggS1zgkGI7iZMcVytgI1WqxALiZjn-s7hK7GA7Ffs0fdVOtKWwCOTDyOPfN_aMvyx7SfAFwbh-FwnBJcsxKfO2wTTHj7IVqeoix01BH2crXGCSlw37dpY9i_EaY1CR-ml2RitS0pqyVXa7m_vcuu-2t8mHA9p4J7VLQSTrXUTeoLVL1sxuL4aIdvM0BR0j2urRD4doHVrLZG9sOizoVRAD2ginrBJIDL2VAmrA_iGZgp8gO9iIuugHkXREJvgRbbuveeeMlkkr1AF8Y9UMVz7PnhgI-sV9PM--fHj_ebPNL68-dpv1ZS6rmqVclH2j2qKsGK4NbllREtwqjHXFmr5XRkktelpRXPWKNAL6byBDjWx73QpDivPszbHuFPyPWcfERxulHgbhtJ8jJxVjDW3qkgL6-i_02s_BwesWCtcFKyn7TcHgNLfOeBiqXIryddFU8F3wMUBd_IOCpfRopXfaWMifCN6eCIBJ-mfaizlG3u0-nbLkyMrgYwza8CnYUYQDJ5gvBuJHA3EwEF8MxDFoXt03N_ejVg-KX44BgB6BCEdur8Mf3f-36h1ZxdCj</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Anil, Sukumaran</creator><creator>Hashem, Mohamed</creator><creator>Vellappally, Sajith</creator><creator>Patil, Shankargouda</creator><creator>Bandara, H. M. H. N.</creator><creator>Samaranayake, L. P.</creator><general>Springer Netherlands</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20141001</creationdate><title>Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals</title><author>Anil, Sukumaran ; Hashem, Mohamed ; Vellappally, Sajith ; Patil, Shankargouda ; Bandara, H. M. H. N. ; Samaranayake, L. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Amphotericin B</topic><topic>Amphotericin B - pharmacology</topic><topic>Antifungal agents</topic><topic>Antifungal Agents - pharmacology</topic><topic>Antiparasitic agents</topic><topic>Biocides</topic><topic>Biomedical and Life Sciences</topic><topic>Candida albicans</topic><topic>Candida albicans - drug effects</topic><topic>Candida albicans - isolation &amp; purification</topic><topic>Candida albicans - metabolism</topic><topic>Candida tropicalis</topic><topic>Candida tropicalis - drug effects</topic><topic>Candida tropicalis - isolation &amp; purification</topic><topic>Candida tropicalis - metabolism</topic><topic>Candidiasis, Oral - microbiology</topic><topic>Dentistry</topic><topic>Enzymes</topic><topic>Eukaryotic Microbiology</topic><topic>Fluconazole</topic><topic>Fluconazole - pharmacology</topic><topic>Fungi</topic><topic>Health aspects</topic><topic>Hemolysin Proteins - antagonists &amp; inhibitors</topic><topic>Hemolysin Proteins - secretion</topic><topic>HIV</topic><topic>HIV (Viruses)</topic><topic>HIV infection</topic><topic>HIV Infections - complications</topic><topic>HIV patients</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infections</topic><topic>Life Sciences</topic><topic>Medical Microbiology</topic><topic>Microbial Ecology</topic><topic>Microbiological Techniques</topic><topic>Microbiology</topic><topic>Nystatin - pharmacology</topic><topic>Plant Sciences</topic><topic>Virulence</topic><topic>Virulence (Microbiology)</topic><topic>Virulence Factors - antagonists &amp; inhibitors</topic><topic>Virulence Factors - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anil, Sukumaran</creatorcontrib><creatorcontrib>Hashem, Mohamed</creatorcontrib><creatorcontrib>Vellappally, Sajith</creatorcontrib><creatorcontrib>Patil, Shankargouda</creatorcontrib><creatorcontrib>Bandara, H. M. H. N.</creatorcontrib><creatorcontrib>Samaranayake, L. P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Mycopathologia (1975)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anil, Sukumaran</au><au>Hashem, Mohamed</au><au>Vellappally, Sajith</au><au>Patil, Shankargouda</au><au>Bandara, H. M. H. N.</au><au>Samaranayake, L. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals</atitle><jtitle>Mycopathologia (1975)</jtitle><stitle>Mycopathologia</stitle><addtitle>Mycopathologia</addtitle><date>2014-10-01</date><risdate>2014</risdate><volume>178</volume><issue>3-4</issue><spage>207</spage><epage>215</epage><pages>207-215</pages><issn>0301-486X</issn><eissn>1573-0832</eissn><abstract>Secretion of hydrolytic enzymes such as hemolysin is considered an important virulence attribute of the opportunistic pathogenic fungus Candida . It is known that Candida spp. isolated from HIV-infected patients produce copious hemolysins. As common antifungal agents may perturb the production of extracellular enzymes, we evaluated the effect of three antifungals nystatin, amphotericin B and fluconazole on the hemolytic activity of Candida albicans and Candida tropicalis isolates from HIV-infected individuals. The impact of antimycotics on hemolytic activity was assessed by a previously described in vitro plate assay, after exposing ten isolates each of C. albicans and C. tropicalis recovered from HIV-infected individuals to sub-minimum inhibitory concentrations (sub-MIC) of nystatin, amphotericin B and fluconazole. All Candida isolates showed a significant reduction in hemolytic activity. The reduction was highest for amphotericin B-exposed C. albicans and C. tropicalis followed by nystatin and fluconazole. The effect of antimycotics was more pronounced on the hemolytic activity of C. tropicalis compared to that of C. albicans . Commonly used antifungal agents significantly suppress hemolysin activity of Candida species. This implies that the antifungals, in addition to their lethality, may modulate key virulence attributes of the yeast. The clinical relevance of this phenomenon in HIV disease and other similar pathologies remains to be determined.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>25142726</pmid><doi>10.1007/s11046-014-9802-0</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-486X
ispartof Mycopathologia (1975), 2014-10, Vol.178 (3-4), p.207-215
issn 0301-486X
1573-0832
language eng
recordid cdi_proquest_miscellaneous_1566828742
source Springer Nature
subjects Amphotericin B
Amphotericin B - pharmacology
Antifungal agents
Antifungal Agents - pharmacology
Antiparasitic agents
Biocides
Biomedical and Life Sciences
Candida albicans
Candida albicans - drug effects
Candida albicans - isolation & purification
Candida albicans - metabolism
Candida tropicalis
Candida tropicalis - drug effects
Candida tropicalis - isolation & purification
Candida tropicalis - metabolism
Candidiasis, Oral - microbiology
Dentistry
Enzymes
Eukaryotic Microbiology
Fluconazole
Fluconazole - pharmacology
Fungi
Health aspects
Hemolysin Proteins - antagonists & inhibitors
Hemolysin Proteins - secretion
HIV
HIV (Viruses)
HIV infection
HIV Infections - complications
HIV patients
Human immunodeficiency virus
Humans
Infections
Life Sciences
Medical Microbiology
Microbial Ecology
Microbiological Techniques
Microbiology
Nystatin - pharmacology
Plant Sciences
Virulence
Virulence (Microbiology)
Virulence Factors - antagonists & inhibitors
Virulence Factors - metabolism
title Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T01%3A11%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sub-inhibitory%20Concentrations%20of%20Antifungals%20Suppress%20Hemolysin%20Activity%20of%20Oral%20Candida%20albicans%20and%20Candida%20tropicalis%20Isolates%20from%20HIV-Infected%20Individuals&rft.jtitle=Mycopathologia%20(1975)&rft.au=Anil,%20Sukumaran&rft.date=2014-10-01&rft.volume=178&rft.issue=3-4&rft.spage=207&rft.epage=215&rft.pages=207-215&rft.issn=0301-486X&rft.eissn=1573-0832&rft_id=info:doi/10.1007/s11046-014-9802-0&rft_dat=%3Cgale_proqu%3EA385802486%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c576t-a4b8d9345607f09634109d00e568bbdfdceab25205bd18a2518cea2fc9be9af13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1560736426&rft_id=info:pmid/25142726&rft_galeid=A385802486&rfr_iscdi=true